At #EHA2026, Johnson and Johnson shows Imaavy demonstrated early and sustained hemoglobin gains in pivotal study for warm autoimmune hemolytic anemia
Track #EHA26 updates here
www.ipharmacenter.com/post/europea...
#news #media #pharmaceutical #Pharma #Oncology
ABBVIEAbbVie shares nine‑year CLL14 results for Venetoclax regimen in previously untreated chronic lymphocytic leukemiaAbbVie has reported final nine‑year data from the Phase 3 CLL14 study, which eval...
